Treatment guidelines and patterns of care in oral cavity squamous cell carcinoma: Primary surgical resection vs. nonsurgical treatment

被引:23
|
作者
Fujiwara, Rance J. T. [1 ]
Burtness, Barbara [2 ,3 ]
Husain, Zain A. [2 ,4 ]
Judson, Benjamin L. [1 ,2 ]
Bhatia, Aarti [2 ,3 ]
Sasaki, Clarence T. [1 ,2 ]
Yarbrough, Wendell G. [1 ,2 ,5 ]
Mehra, Saral [1 ,2 ]
机构
[1] Yale Univ, Sch Med, Dept Surg Otolaryngol, New Haven, CT USA
[2] Yale Canc Ctr, New Haven, CT USA
[3] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA
[4] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA
[5] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
关键词
Oral cancer; Squamous cell carcinoma; Guideline adherence; Health services; Quality of care; MISSING DATA; CANCER; SURVIVAL; HEAD; OUTCOMES; SURGERY; BASE; EFFICACY; ADJUVANT; THERAPY;
D O I
10.1016/j.oraloncology.2017.06.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The 2017 National Comprehensive Cancer Network Clinical Practice Guidelines recommend surgical resection or definitive radiation therapy for early-stage oral cavity malignancies, and surgical resection or multimodality clinical trials for late-stage disease. Few studies have been conducted to identify predictors of choice of treatment modality for oral cavity malignancies. Methods: All patients in the National Cancer Data Base (NCDB) diagnosed with oral cavity squamous cell carcinoma (OCSCC) between 1998 and 2011 were identified. Chi-square and binary logistic regression were used to identify factors predictive of surgical or nonsurgical treatment; multiple imputation was used for missing data. Cox proportional hazards models were generated to identify associations between treatment modality and overall survival (OS). Results: Of 23,459 patients, 4139 (17.6%) underwent primary nonsurgical treatment. Among NCDBregistered facilities, there has been a decrease in use of nonsurgical treatment for OCSCC (OR 0.97, p < 0.001). Older age, non-white race, Medicaid insurance, low income, low education, and later-stage disease were associated with nonsurgical therapy, while patients at academic/research programs were more likely to undergo surgery (OR 0.38, p < 0.001). Nonsurgical treatment was associated with decreased OS (HR = 2.02, p < 0.001); this was upheld on subgroup analysis of early-and late-stage disease. Conclusions: Use of primary nonsurgical treatment for OCSCC has decreased over time among NCDBregistered facilities and is associated with factors related to access to care. Surgical resection for the primary treatment of oral cavity cancer may be associated with improved OS, though conclusions regarding survival are limited by the non-randomized nature of the data. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:129 / 137
页数:9
相关论文
共 50 条
  • [31] Selected parameters of blood coagulation and fibrinolysis prior to and after surgical treatment of squamous cell carcinoma of the oral cavity
    Knapik, J
    Korabiowska, M
    Hönig, JF
    Grohmann, U
    Undas, A
    Bartkowski, SB
    Brinck, U
    ANTICANCER RESEARCH, 2002, 22 (03) : 1873 - 1875
  • [32] Variation in treatment and outcome in the early stage oral cavity squamous cell carcinoma
    Gogarty, Darragh S.
    Lennon, Paul
    Deady, Sandra
    O'Sullivan, J. Barry
    McArdle, Orla
    Leader, Mary
    Sheahan, Patrick
    O'Neill, James Paul
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2017, 274 (02) : 953 - 960
  • [33] Racial disparities in the choice of definitive treatment for squamous cell carcinoma of the oral cavity
    Lewis, Carol M.
    Ajmani, Gaurav S.
    Kyrillos, Alexandra
    Chamberlain, Paul
    Wang, Chi-Hsiung
    Nocon, Cheryl C.
    Peek, Monica
    Bhayani, Mihir K.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2018, 40 (11): : 2372 - 2382
  • [34] SQUAMOUS-CELL CARCINOMA OF THE ORAL CAVITY - A RETROSPECTIVE ANALYSIS OF TREATMENT AND PROGNOSIS
    WILDT, J
    BJERRUM, P
    ELBROND, O
    CLINICAL OTOLARYNGOLOGY, 1989, 14 (02) : 107 - 113
  • [35] Inositol hexaphosphate and paclitaxel: Symbiotic treatment of oral cavity squamous cell carcinoma
    Janus, Seth C.
    Weurtz, Beverly
    Ondrey, Frank G.
    LARYNGOSCOPE, 2007, 117 (08): : 1381 - 1388
  • [36] Variation in treatment and outcome in the early stage oral cavity squamous cell carcinoma
    Darragh S. Gogarty
    Paul Lennon
    Sandra Deady
    J. Barry O’Sullivan
    Orla McArdle
    Mary Leader
    Patrick Sheahan
    James Paul O’Neill
    European Archives of Oto-Rhino-Laryngology, 2017, 274 : 953 - 960
  • [37] Survival evaluation of treatment modality in squamous cell carcinoma of the oral cavity and oropharynx
    Pericot, J
    Escribà, JM
    Valdés, A
    Biosca, MJ
    Monner, A
    Castellsagué, X
    Galiana, R
    Piulachs, P
    Escutia, E
    Mari, A
    JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2000, 28 (01) : 49 - 55
  • [38] Primary Surgical Treatment in Very Advanced (T4b) Oral Cavity Squamous Cell Carcinomas
    Patel, Evan J.
    Oliver, Jamie R.
    Vaezi, Alec
    Li, Zujun
    Persky, Michael
    Tam, Moses
    Hu, Kenneth S.
    Jacobson, Adam S.
    Givi, Babak
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2021, 165 (03) : 431 - 437
  • [39] Oncologic and Functional Outcomes of Surgical and Nonsurgical Treatment of Advanced Squamous Cell Carcinoma of the Supraglottic Larynx
    Elegbede, Adekunle I.
    Rybicki, Lisa A.
    Adelstein, David J.
    Kaltenbach, James A.
    Lorenz, Robert R.
    Scharpf, Joseph
    Burkey, Brian B.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2015, 141 (12) : 1111 - 1117
  • [40] Salvage surgery as the primary treatment for recurrent oral squamous cell carcinoma
    Lin, YC
    Hsiao, JR
    Tsai, ST
    ORAL ONCOLOGY, 2004, 40 (02) : 183 - 189